Q1 2026 Dri Healthcare Trust Earnings Call Transcript
Key Points
- DRI Healthcare Trust (DHTRF) reported a double-digit royalty income growth of 18%, contributing to a total income of $50.6 million, marking a 15% year-over-year growth.
- The company achieved a first-quarter adjusted EBITDA margin of 90%, setting a company record.
- DRI Healthcare Trust (DHTRF) successfully completed two financing transactions, strengthening its balance sheet and positioning the company for long-term success.
- The company reduced its preferred shares outstanding by partially redeeming and canceling $9.9 million of face value of Series C preferred securities.
- DRI Healthcare Trust (DHTRF) entered the US private placement market, diversifying access to capital and opening a new source of long-term institutional financing.
- Total cash receipts for the first quarter of 2026 decreased by 6% compared to Q1 2025, driven by a one-time payment in the previous year and lower receipts from certain products.
- Spinraza cash receipts were down 8% year-over-year due to lower demand and competition from Roche's products.
- The company recognized a loss on debt refinancing of $9.8 million related to the preferred securities conversion.
- DRI Healthcare Trust (DHTRF) anticipates a slight decrease in operating margins beginning in Q2 due to reinvestment of synergies back into the business.
- The company faced softer performance from certain assets like Bonzhou, Rydapt, and Aratia, partially offsetting strong comps from other products.
Good morning, everyone. Welcome to DRI Healthcare Trust's 2026 first quarter earnings call.
Listeners are reminded that certain statements made in this earnings call presentation, including responses to questions, may contain forward-looking statements within the meeting of the safe harbor provisions of Canadian provincial securities laws.
Forward-looking statements involve risks, uncertainties, and undue reliance should not be placed on such statements.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
For additional information about factors that may cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements, please consult the MD&A for this quarter.
The Risk Factors section of the Annual Information Form and DRI Healthcare's other filings with Canadian securities regulators.
DRI Healthcare does not undertake to update any
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

